Search for: "ELI LILLY & CO."
Results 801 - 820
of 1,009
Sorted by Relevance
|
Sort by Date
15 Jun 2011, 4:56 am
(Patent Docs) Strattera (Atomoxetine)- US: Patent infringement complaint filed in response to Para IV certification: Eli Lilly & Co. v. [read post]
8 Oct 2019, 9:44 am
”) Eli Lilly and Company v. [read post]
21 Oct 2009, 6:13 am
In re KGK Synergize (non precedential) (Patently-O) US: Myriad sticks to its business model despite legal action brought by PUBPAT and others: Association for Molecular Pathology v USPTO (Patent Docs) US: Amazing race: Win $250,000 for commercialising biomedical research (Patent Baristas) US: BIO survey on technology transfer shows complexity of university-industry relationships (PatentBIOtech) Products Adderall (Dextroamphetamine, Amphetamine) – US: Shire announces settlement… [read post]
21 Oct 2009, 5:13 am
In re KGK Synergize (non precedential) (Patently-O) US: Myriad sticks to its business model despite legal action brought by PUBPAT and others: Association for Molecular Pathology v USPTO (Patent Docs) US: Amazing race: Win $250,000 for commercialising biomedical research (Patent Baristas) US: BIO survey on technology transfer shows complexity of university-industry relationships (PatentBIOtech) Products Adderall (Dextroamphetamine, Amphetamine) - US: Shire announces settlement with Sandoz over… [read post]
21 Oct 2009, 5:13 am
In re KGK Synergize (non precedential) (Patently-O) US: Myriad sticks to its business model despite legal action brought by PUBPAT and others: Association for Molecular Pathology v USPTO (Patent Docs) US: Amazing race: Win $250,000 for commercialising biomedical research (Patent Baristas) US: BIO survey on technology transfer shows complexity of university-industry relationships (PatentBIOtech) Products Adderall (Dextroamphetamine, Amphetamine) - US: Shire announces settlement with Sandoz over… [read post]
23 Sep 2017, 12:39 pm
Cir. 2015); Eli Lilly, 845 F.3d at 1370. [read post]
13 Apr 2010, 10:26 am
Eli Lilly & Co., No. 2008-1248, 2010 WL 1007369 (Fed. [read post]
18 Oct 2007, 10:33 pm
Eli Lilly & Co., No. 91-02496-A (Tex. [read post]
1 Dec 2017, 11:35 am
Big pharma players such as Eli Lilly, Novo Nordisk and Allergan are committed to voluntary price restraints, while companies such as Novartis and Roche are in favor of value-based pricing. [read post]
28 Dec 2007, 1:00 am
International Trade Commission and Flexsys America: CAFC instructs the ITC on claim construction: (IPBiz), (Patent Prospector), (more from IPBiz)Anonymised net drug sales might yet infringe - Eli Lilly & Company and Lilly Icos LLC v 8PM Chemists Ltd: (IPKat),Open source for cost effective drug discovery: (Spicy IP),Challenges to ethical and generic drug producers: (Profitability through simplicity),US: multiple courts -… [read post]
11 Jan 2019, 4:00 am
In the UK, the Supreme Court in 2017 released its decision in Actavis UK Ltd v Eli Lilly & Co [2017] UKSC 48 which allowed for variants in claim construction. [read post]
8 Jan 2009, 4:07 am
Eli Lilly & Co., 536 F. [read post]
9 Mar 2020, 3:19 pm
” Actavis UK Ltd v Eli Lilly and Co [2017] UKSC 48 (Lord Kitchin JSC). [read post]
29 Dec 2011, 6:50 am
Eli Lilly & Co., No. 1:07–cv–1133–SEB–TAB, 2008 WL 5384340, at *2 (S.D.Ind. [read post]
7 Jan 2014, 7:46 am
See, e.g, In re Eli Lilly & Co., No. 3:09MC296 (AWT), 2010 WL 2509133, at *4 (D. [read post]
10 Feb 2010, 11:56 am
Eli Lilly & Co., 485 N.E.2d 551, 553 (Ill. [read post]
23 Apr 2012, 3:33 am
Bristol and Eli Lilly and Co. make Erbitux at $100,000 per year. [read post]
1 Feb 2007, 6:07 am
Eli Lilly & Co., 1420 A.2d 1305, 1320 (N.J. [read post]
9 Jun 2011, 10:02 am
Eli Lilly & Co., 2009 WL 5216930, at *12 (E.D.N.Y. [read post]
19 Sep 2013, 9:53 am
The following post is exclusively the work of the Reed Smith side of the blog.Sometimes the smallest, least significant type of lawsuit can illustrate cracks in the edifice of the largest, most consequential litigation. [read post]
